False
October 8, 2026
4 min read
We asked the 2026 Power List whether newer modalities have eclipsed small molecules – and where the traditional mainstay still wins
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
October 1, 2026
3 min read
Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made
September 30, 2026
10 min read
How direct T-cell reprogramming could simplify CAR-T manufacturing, expand patient access, and extend cellular immunotherapy to new indications
False